ICP DAS Brings Energy Management and Safety Monitoring to the Forefront at IIFES 2025
HSINCHU, Nov. 6, 2025 /PRNewswire/ -- ICP DAS is pleased to announce…
2026 Hyundai IONIQ 9 and 2026 Kia Sportage Earn 2025 IIHS TOP SAFETY PICK + Honors
2026 Hyundai IONIQ 9 and 2026 Kia Sportage (built after May 2025)…
Nanoscope Therapeutics Reports Five-Year Safety Results from Phase 1/2a Follow-Up Study of MCO-010 Optogenetic Therapy in Retinitis Pigmentosa
DALLAS, Nov. 4, 2025 /PRNewswire/ -- Nanoscope Therapeutics Inc. announced today positive…
2026 Kia Sportage Named 2025 TOP SAFETY PICK+ in 2025 IIHS Crash Test Ratings
2026 Kia SPORTAGE earns highest-tier 2025 TOP SAFETY PICK+ (TSP+) rating from…
Award-Winning Film An Inconvenient Study Sparks Global Debate on Vaccine Safety and Chronic Disease
AUSTIN, Texas, Oct. 23, 2025 (GLOBE NEWSWIRE) -- The award-winning film An Inconvenient…
LEPAS Hosts Its First Public Safety Test, Defining “Elegant Driving” Through Safety
WUHU, China, Oct. 22, 2025 /PRNewswire/ -- In the new era of…
ACM Biolabs Reports Favorable Safety Signals and Early Pharmacodynamics from Intramuscular Administration of ACM-CpG in Patients with Advanced Solid Tumors
SINGAPORE, Oct. 22, 2025 /PRNewswire/ -- ACM Biolabs, a clinical-stage biotechnology company developing next-generation…
Internet Watch Foundation and Public Interest Registry Extend Online Safety Initiative to Disrupt Criminal ‘brands’ Selling Child Sexual Abuse
A new sponsorship programme aims to help domain registrars 'disrupt' criminal businesses…
SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology
Long-term continuous OGSIVEO treatment for up to 4 years was associated with…
First Key Update of the International AI Safety Report released
MONTREAL, Oct. 15, 2025 /PRNewswire/ -- The first Key Update of the…
